Bio-Rad Laboratories | BIO - Current Liabilities


Bio-Rad Laboratories reported $517M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agilent USD 2.23B 113M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Danaher USD 6.81B 483M Dec/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Illumina USD 1.59B 377M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Quest Diagnostics USD 2.28B 144M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Siemens EUR 49.35B 2.09B Dec/2025
Standard Biotools USD 108.31M 343K Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Tosoh JPY 340.28B 25.85B Dec/2025
Waters USD 1.24B 11.8M Dec/2025